Operations disrupted at NATCO Pharma's Manali, Chennai factory
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
Profit after tax (before exceptional items) up 23% to Rs 215 crores
API, PFI, and Finished dosages contribute 30%, 15%, and 55% of revenue from operations respectively for Q1FY24
Establishes distribution center in top hub for international shipping
The OMRON Healthcare factory will be built over 6.02 acres and will be manufacturing blood pressure monitors and supplying them mainly to the domestic market.
The balance of AUD 94 Million was a deferred consideration backed by a secured interest-bearing instrument
GMP-compliant documentation of all manufacturing steps for cell and gene therapies
Company raises the annual revenue guidance from mid-teens to high teens
Prior to this, Maria held multiple roles at Novartis including Head of Global Manufacturing Functions, and Global Head of Manufacturing, Science & Technology
Subscribe To Our Newsletter & Stay Updated